Colorectal cancer tumor stem cells mediate bevacizumab resistance through the signal IL-22-STAT3 signaling pathway.

Saved in:
Bibliographic Details
Title: Colorectal cancer tumor stem cells mediate bevacizumab resistance through the signal IL-22-STAT3 signaling pathway.
Authors: Qin, Xiaoning1 (AUTHOR), Ruan, Hongxun1 (AUTHOR), Yuan, Liqing2 (AUTHOR), Lin, Lin1 (AUTHOR) linlin779242000@outlook.com
Source: 3 Biotech. 9/1/2023, Vol. 13 Issue 10, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2190572X
DOI:10.1007/s13205-023-03742-5